Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:57:30.700Z.
Calculation as of: 2026-10-06T15:57:30.700Z.
Quote observation: 2026-10-06T15:55:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 869efbf6e11e98c8b36b953a9b631e7639c239a9e2012f11ad9cca4b0e6b7a7d
EARNINGS YIELD
N/A
Market Cap
$669.83M
Earnings Yield
0.87%
TTM Avg
4.56%
3Y Avg
4.76%
5Y Avg
4.76%
Market Cap
$675.41M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OmniAb, Inc. (OABI) | $642.95M | N/A | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $643.37M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $637.34M | N/A | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $630.50M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $669.83M | 0.87% | 4.56% | 4.76% | 4.76% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $675.41M | N/A | N/A | N/A | N/A |
| ArriVent BioPharma, Inc. (AVBP)vs › | $616.19M | N/A | N/A | N/A | N/A |
| AngioDynamics, Inc. (ANGO)vs › | $610.69M | N/A | 2.32% | 2.32% | 1.62% |
| Annexon, Inc. (ANNX)vs › | $684.04M | N/A | N/A | N/A | N/A |
| Helus Pharma Inc. (HELP)vs › | $685.54M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
